Our Team

Leadership that inspires solutions.

Banks Bourne

Founder and Chairman | bbourne@bourne-partners.com

Banks Bourne is the Founder and Chairman of Tanner Pharma Group (“Tanner Pharma”). Banks started the company in 2003 when a patient in South America needed a lifesaving drug, but had no local access. Through his industry knowledge and longstanding relationships, Banks found a way to procure the medication and the rest is history. Today, Tanner Pharma is dedicated to providing managed access, commercialization and clinical trials services to patients and partners in more than 100 countries.

Banks is also the founder of Bourne Partners, a leading financial services firm. For over 20 years, Bourne Partners has transacted with nearly all major pharmaceutical and specialty pharmaceuticals companies around the world, including Banks’ initial investment in King Pharmaceuticals in the late 1990’s. This investment introduced Banks to the pharmaceutical world and jumpstarted his interest in the healthcare sector. Since then, Bourne Partners has been party to more than $10 billion of transactions in pharmaceutical (“pharma”), pharma services and consumer health, and Banks has invested in more than 200 private companies / assets since 2000. Most recently the Bourne Team and other partners co-founded Covis Pharma S.à.r.l. in 2011, successfully helping build and eventually divest the majority of assets in 2015 for $1.2 billion. In late 2015 the firm established Phoenix Therapeutics, Inc., a joint venture with The Carlyle Group.

Prior to founding Bourne Partners, Banks held the position of Senior Vice President of Corporate Development for TITAN Technology Partners and also worked in the investment banking field for Wachovia Securities, Inc. He received a B.A. degree in Business Management (Magna Cum Laude) from North Carolina State University and a M.B.A. from Wake Forest University. He is a member of Young Presidents Organization (YPO).

While Banks has derived great satisfaction by offering focused advisory services to, and investing in pharma, healthcare, and consumer oriented companies that need strategic and operational insights; he is even more gratified by knowing that his work has helped companies to improve the health and well-being of patients across the world.

Outside of work, Banks enjoys supporting the interests and activities of his wife and children, traveling to new and interesting destinations and pursuing his passion for golf. He also actively supports the Levine Children’s Hospital and Levine Cancer Institute, both part of Atrium Health (formerly known as Carolinas HealthCare System). Banks is passionate about providing healthcare and specifically pharmaceuticals to less fortunate patients as demonstrated by supporting these priorities through The Bourne Foundation, The Max Foundation, Partners in Health and other non-profit organizations.

Steve Scalia

President | sscalia@tannerpharma.com

Steve leads all business activities at Tanner Pharma Group, including oversight of the commercial divisions, the cross-functional departments, the Corporate Governance Team and the Senior Management Team.  Prior to joining Tanner Pharma in 2011, he owned three, entrepreneurial start-ups that included complex operating models and custom facilities requiring real estate development.  Steve began his career in the pharma industry, holding sales and management positions at Upjohn Pharmaceuticals and Pharmacia Corp.

Maryori Alvarenga

Global Head of TannerGAP, Managing Director US | malvarenga@tannerpharma.com

Maryori oversees the US office while also leading the Global Access Programs division. As one of the first employees at Tanner Pharma Group, Maryori is an expert in every facet of the business with previous roles including marketing, sales management, operations management, and research. She also earned a double degree in Management and Marketing from the University of North Carolina at Charlotte.

Jonathan Bracey

EVP of Corporate Development, Global Head of TannerCTS & Managing Director UK | jbracey@tannerpharma.com

Jonathan oversees the UK Office while also leading the Clinical Trial Supplies division. He also leads efforts to expand our partnerships around the world as the Executive VP of Corporate Development. Jonathan's experience ranges from Generics, Big Pharma, Specialty Pharma and most recently consultancy within the pharmaceutical industry. Within these organisations, he worked in general management, operations, sales, procurement and supply chain roles with UK, EU, MENA and Global reach. Jonathan also served as a logistics officer in HM Forces.

Carolina Cortez

Global Head of TannerLAC | ccortez@tannerpharma.com

Carolina leads all business activities for the Licensing, Acquisition & Commercial division including Partner Relations, Business Development and Commercialization Strategies. With over 16 years of international pharmaceutical experience, fluency in English, Spanish and Portuguese, and a Bachelor of Business Administration degree from University of North Carolina at Charlotte, Carolina is uniquely suited to drive value in international markets.

Robert Keel

Global Head of TannerMAP, Managing Director CH | rkeel@tannerpharma.com

Rob oversees the Swiss Office while also leading the Managed Access Programs division. He has lived and worked extensively across the EMEA and Asia Pacific regions and has held global general management and finance roles within the pharmaceutical, airline and agriculture industries.  Within the pharmaceutical industry, Rob has previously been responsible for the management and operation of the EMEA commercial supply chain at AstraZeneca and led business development activities at UK-based Alliance Healthcare. Rob holds an Industrial Engineering and Management Sciences degree from Northwestern University and an MBA from Harvard Business School.

John Coyle

Global Director of Quality and Regulatory Affairs | jcoyle@tannerpharma.com

John is the Global Director of Quality and Regulatory Affairs for Tanner Pharma Group. With over 30 years of pharmaceutical industry experience, John has covered the entire life cycle of pharma products from pre-clinical testing, to dossier submission, manufacturing, testing, and stability. He has been the site quality leader for a large variety of dosage forms including solid oral dose, liquids, metered dose inhalers, sterile injectables, OTC, Dietary Supplements and medical devices.  John has spent time at a number of major pharmaceutical companies including Allergan, GlaxoSmithKline, Teva, Proctor and Gamble, and Catalent. He has extensive experience working with the FDA and a variety of global regulatory agencies. John has a Bachelor of Science degree in Biology from the State University of NY at Old Westbury.

Jim Leonard

Global Director of Finance & Accounting | jleonard@tannerpharma.com

Jim heads up the Finance and Accounting function for all of Tanner’s Global operations. He has 30+ years of hands on experience with international businesses ranging from privately held entities to Fortune 500s.  Mr. Leonard has served in both the Manufacturing and Services sectors, holds Accounting/Finance degrees, and is a Licensed Certified Public Accountant.

Bill Taylor

Global Director of Legal & Compliance | wtaylor@tannerpharma.com

Bill is responsible for coordinating all legal and compliance issues for the company's activities. He has a wide range of experience in dealing with U.S. and non-U.S. attorneys involving international law issues. Mr. Taylor has established an active attorney network in more than forty countries relating to intellectual property, corporate law, labour law, and product distribution legal matters. Prior to joining Tanner Pharma Group, Mr. Taylor had extensive litigation experience in the private practice of law in Kentucky from 1975 until joining King Pharmaceuticals International as Director of International Legal Affairs in 1999. He is a member of the Kentucky Bar Association and a former member of the American Trial Lawyers Association.

Matt Way

Global Director of Supply Chain & Logistics | mway@tannerpharma.com

Matt joined the Tanner team in 2019 and leads the Supply Chain and Logistics operations division. Matt has a wealth of experience in dealing with difficult and challenging Supply Chains around the world - including humanitarian relief support from his time in the British Army. Following his retirement from the military, Matt spent 6 years in Australia where he performed various Supply Chain roles including Head of Logistics for one of Asia Pacific’s largest retailers. Matt holds a Master’s degree in Business from the University of New South Wales.

Katie Smoot

Global Director of Business Management | Ksmoot@tannerpharma.com

Katie joined the team in 2019 to oversee Global Project Implementation, IT & Infrastructure, Team Development & HR activities. She has over 17 years of project and change management experience, combined with diverse business support experience for international teams; focused on technology, human resources, and risk. Katie has a degree in Marketing and Communications from Clemson University and is a Six Sigma Certified Blackbelt, focused on Lean and Design methodologies.

John Lagus

Managing Director of Business Development | Jlagus@tannerpharma.com

John joined the Tanner team in 2019 and oversees the business development activities with a focus on Managed Access Programs.  John began his career by applying his master’s degree in Statistics to clinical trials at The University of Minnesota and the pharmaceutical division of 3M Company.  Then he spent 11 years at Orphan Medical where he held various development, sales, marketing and commercial roles, eventually overseeing their international business unit.  Prior to joining Tanner Pharma, John worked for 12 years at Idis (and subsequently Clinigen after the merger of the two).  While at Idis/Clinigen, John spent his entire time in their MAP Division performing Business Development and General Management roles of increasing responsibility.